Gilead to help boost production of remdesivir in India, promises to donate 4.50 lakh vials

American biopharmaceutical company Gilead has announced steps to boost remdesivir production in India as the country sees a surge in the Covid-19 cases. It has also announced to donate 4.50 lakh vials to India.

American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe disease. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, chief commercial officer of Gilead Sciences said on Monday.